Literature DB >> 9016381

Current applications of polysaccharides in colon targeting.

L Hovgaard1, H Brøndsted.   

Abstract

Polysaccharides have over the years been used widely in pharmaceutical, chemical, and biochemical drug delivery. This family of natural polymers has an appeal to the area of drug delivery as it is comprised of polymers with a large number of derivatizable groups, a wide range of molecular weights, varying chemical compositions, and for the most part, a low toxicity and biodegradability, yet a high stability. The main scope of this review is to relate the polysaccharides available now to the rapidly growing field of colonic drug delivery. Polysaccharides have been applied to the area as controlled release coatings, matrices, macromolecular carriers, and biodegradable carriers. Bacterial sources of polysaccharidases as well as a detailed treatise of the enzymatic flora of the colonic region are discussed, followed by a presentation of the polysaccharides available for the purpose of colon-specific drug delivery. A final overview of the various approaches to obtain colon-specific delivery by using polysaccharides and a summary of available in vitro and in vivo testing methods will lead to the conclusion that polysaccharides at this point appear to be very promising compounds for use in obtaining colon-specific drug delivery systems.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9016381     DOI: 10.1615/critrevtherdrugcarriersyst.v13.i3-4.10

Source DB:  PubMed          Journal:  Crit Rev Ther Drug Carrier Syst        ISSN: 0743-4863            Impact factor:   4.889


  15 in total

1.  Extrusion/spheronization of pectin-based formulations. I. Screening of important factors.

Authors:  T Tho; P Kleinebudde; S A Sande
Journal:  AAPS PharmSciTech       Date:  2001-12-01       Impact factor: 3.246

2.  Preparation and In vitro Investigation of Chitosan Compressed Tablets for Colon Targeting.

Authors:  Negar Bashardoust; Josephine Leno Jenita; Parvin Zakeri-Milani
Journal:  Adv Pharm Bull       Date:  2011-12-15

3.  Effect of colonic lactulose availability on the timing of drug release onset in vivo from a unique colon-specific drug delivery system (CODES).

Authors:  Libo Yang; Shunsuke Watanabe; Jinhe Li; James S Chu; Musataka Katsuma; Shigeharu Yokohama; Joseph A Fix
Journal:  Pharm Res       Date:  2003-03       Impact factor: 4.200

Review 4.  Impact of gastric and bowel surgery on gastrointestinal drug delivery.

Authors:  Susan Hua; Ephraem C Lye
Journal:  Drug Deliv Transl Res       Date:  2022-05-18       Impact factor: 4.617

5.  Chitosan-chondroitin sulfate based matrix tablets for colon specific delivery of indomethacin.

Authors:  Jitendra R Amrutkar; Surendra G Gattani
Journal:  AAPS PharmSciTech       Date:  2009-05-21       Impact factor: 3.246

6.  Development of pH sensitive polyacrylamide grafted pectin hydrogel for controlled drug delivery system.

Authors:  Prashant B Sutar; Rakesh K Mishra; Kunal Pal; Ajit K Banthia
Journal:  J Mater Sci Mater Med       Date:  2007-07-10       Impact factor: 3.896

Review 7.  Insight to drug delivery aspects for colorectal cancer.

Authors:  Arvind Gulbake; Aviral Jain; Ashish Jain; Ankit Jain; Sanjay K Jain
Journal:  World J Gastroenterol       Date:  2016-01-14       Impact factor: 5.742

8.  Development and evaluation of microbial degradation dependent compression coated secnidazole tablets for colonic delivery.

Authors:  B K Sridhar; A Srinatha; B B Zaman; H Ragunandan
Journal:  Indian J Pharm Sci       Date:  2011-11       Impact factor: 0.975

9.  A nanomedicine-promising approach to provide an appropriate colon-targeted drug delivery system for 5-fluorouracil.

Authors:  Sima Singh; Niranjan G Kotla; Sonia Tomar; Balaji Maddiboyina; Thomas J Webster; Dinesh Sharma; Omprakash Sunnapu
Journal:  Int J Nanomedicine       Date:  2015-11-23

10.  Probiotic encapsulation technology: from microencapsulation to release into the gut.

Authors:  Gildas K Gbassi; Thierry Vandamme
Journal:  Pharmaceutics       Date:  2012-02-06       Impact factor: 6.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.